Zurcher Kantonalbank (Zurich Cantonalbank) Biogen Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Biogen Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 69,649 shares of BIIB stock, worth $10.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

69,649

Previous 69,649 -0.0%

Holding current value

$10.1 Million

Previous $13.5 Million -0.0%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$189.07 - $236.8 $700,882 - $877,817	-3,707 Reduced 5.05%	69,649 $13.5 Million
Q2 2024 Jul 29, 2024	SELL	$190.52 - $236.72 $380,849 - $473,203	-1,999 Reduced 2.65%	73,356 $17 Million
Q1 2024 Apr 25, 2024	SELL	$212.02 - $267.71 $19.9 Million - $25.2 Million	-94,026 Reduced 55.51%	75,355 $16.2 Million
Q4 2023 Jan 30, 2024	SELL	$222.59 - $267.94 $10 Million - $12.1 Million	-45,019 Reduced 21.0%	169,381 $43.8 Million
Q3 2023 Oct 25, 2023	BUY	$253.3 - $285.89 $3.96 Million - $4.47 Million	15,627 Added 7.86%	214,400 $55.1 Million
Q2 2023 Aug 07, 2023	BUY	$275.25 - $318.06 $4.75 Million - $5.49 Million	17,253 Added 9.5%	198,773 $56.6 Million
Q1 2023 May 08, 2023	BUY	$256.56 - $292.34 $8.08 Million - $9.2 Million	31,483 Added 20.98%	181,520 $50.5 Million
Q4 2022 Feb 01, 2023	BUY	$252.44 - $306.72 $11.9 Million - $14.5 Million	47,302 Added 46.04%	150,037 $41.5 Million
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $4.04 Million - $5.57 Million	20,756 Added 25.32%	102,735 $27.4 Million
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $2.14 Million - $2.54 Million	-11,389 Reduced 12.2%	81,979 $16.7 Million
Q1 2022 Apr 21, 2022	SELL	$193.77 - $244.14 $743,883 - $937,253	-3,839 Reduced 3.95%	93,368 $19.7 Million
Q4 2021 Feb 01, 2022	BUY	$223.92 - $287.77 $4.33 Million - $5.57 Million	19,344 Added 24.84%	97,207 $23.3 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $2.34 Million - $3.05 Million	8,272 Added 11.89%	77,863 $22 Million
Q2 2021 Jul 30, 2021	BUY	$259.0 - $414.71 $1.66 Million - $2.65 Million	6,401 Added 10.13%	69,591 $24.1 Million
Q1 2021 May 03, 2021	SELL	$242.95 - $284.63 $539,591 - $632,163	-2,221 Reduced 3.4%	63,190 $17.7 Million
Q4 2020 Jan 28, 2021	BUY	$236.26 - $355.63 $21,499 - $32,362	91 Added 0.14%	65,411 $16 Million
Q3 2020 Nov 06, 2020	SELL	$264.77 - $305.71 $223,995 - $258,630	-846 Reduced 1.28%	65,320 $18.5 Million
Q2 2020 Jul 28, 2020	SELL	$258.66 - $342.55 $2.33 Million - $3.09 Million	-9,017 Reduced 11.99%	66,166 $17.7 Million
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $7.43 Million - $9.42 Million	27,629 Added 58.1%	75,183 $23.8 Million
Q4 2019 Jan 21, 2020	SELL	$220.06 - $304.07 $1.3 Million - $1.79 Million	-5,897 Reduced 11.03%	47,554 $14.1 Million
Q3 2019 Oct 18, 2019	BUY	$217.44 - $243.88 $178,735 - $200,469	822 Added 1.56%	53,451 $12.4 Million
Q2 2019 Jul 30, 2019	SELL	$219.29 - $241.72 $6.33 Million - $6.98 Million	-28,873 Reduced 35.43%	52,629 $12.3 Million
Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $15 Million - $23.5 Million	-69,235 Reduced 45.93%	81,502 $19.3 Million
Q4 2018 Jan 25, 2019	BUY	$278.5 - $352.75 $3.95 Million - $5.01 Million	14,191 Added 10.39%	150,737 $45.4 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $3.81 Million - $4.98 Million	-12,977 Reduced 8.68%	136,546 $48.2 Million
Q2 2018 Aug 06, 2018	SELL	$257.52 - $306.91 $7.76 Million - $9.25 Million	-30,151 Reduced 16.78%	149,523 $43.4 Million
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $5.39 Million - $7.62 Million	20,710 Added 13.03%	179,674 $49.2 Million
Q4 2017 Jan 31, 2018	BUY	$307.64 - $344.58 $9.11 Million - $10.2 Million	29,597 Added 22.88%	158,964 $50.6 Million
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $36.4 Million - $42.7 Million	129,367	129,367 $40.5 Million

Others Institutions Holding BIIB

# of Institutions

1,000

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Biogen Inc. Transaction History